Influence of arginine deimination on antigenicity of fibrinogen

Journal of Autoimmunity

Volumn 23, Issue 2, 2004, Pages 141-150

  Hida, Shunsuke ^a   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Antigenicity; Autoantibodies; Deiminated fibrinogen; Peptidyl arginine deiminase; Rheumatoid arthritis

Indexed keywords

ADJUVANT; ANTIBODY; ARGININE; CYCLIC CITRULLINATED PEPTIDE; DEIMINATED FIBRINOGEN; FIBRINOGEN; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; ARGININE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; FIBRINOGEN; HYDROLASES; IMINES; MICE; MICE, INBRED BALB C;

EID: 8444221895     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2004.06.002     Document Type: Article

References (26)

1. Bookbinder S.A., Espinoza L.R., Fenske N.A., Germain B.F., Vasey F.B. Methotrexate: its use in the rheumatic diseases. Clin Exp Rheumatol. 2:(2):1984 Apr-Jun;185-193
2. Bannwarth B., Labat L., Moride Y., Schaeverbeke T. Methotrexate in rheumatoid arthritis. An update. Drugs. 47:(1):1994 Jan;25-50
3. Daoud K.F., Jackson C.G., Williams H.J. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs. Compr Ther. 25:(8-10):1999 Aug-Oct;427-433
4. Elliott M.J., Maini R.N., Feldmann M., Long-Fox A., Charles P., Katsikis P., et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 36:(12):1993 Dec;1681-1690
5. Moreland L.W., Baumgartner S.W., Schiff M.H., Tindall E.A., Fleischmann R.M., Weaver A.L., et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 337:(3):1997 Jul 17;141-147
6. Nishimoto N., Kishimoto T., Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 59:(Suppl. 1):2000 Nov;i21-i27
7. Hannum C.H., Wilcox C.J., Arend W.P., Joslin F.G., Dripps D.J., Heimdal P.L., et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 343:(6256):1990 Jan 25;336-340
8. Bresnihan B., Alvaro-Gracia J.M., Cobby M., Doherty M., Domljan Z., Emery P., et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 41:(12):1998 Dec;2196-2204
9. Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 344:(12):2001 Mar 22;907-916
10. Goldbach-Mansky R., Lee J., McCoy A., Hoxworth J., Yarboro C., Smolen J.S., et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2:(3):2000;236-243
11. Sebbag M., Simon M., Vincent C., Masson-Bessiere C., Girbal E., Durieux J.J., et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest. 95:(6):1995 Jun;2672-2679
12. Simon M., Girbal E., Sebbag M., Gomes-Daudrix V., Vincent C., Salama G., et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest. 92:(3):1993 Sep;1387-1393
13. Vincent C., Simon M., Sebbag M., Girbal-Neuhauser E., Durieux J.J., Cantagrel A., et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol. 25:(5):1998 May;838-846
14. Girbal-Neuhauser E., Durieux J.J., Arnaud M., Dalbon P., Sebbag M., Vincent C., et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 162:(1):1999 Jan 1;585-594
15. Masson-Bessiere C., Sebbag M., Girbal-Neuhauser E., Nogueira L., Vincent C., Senshu T., et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. Immunology. 166:(6):2001 Mar 15;4177-4184
16. Schellekens G.A., de Jong B.A., van den Hoogen F.H., van de Putte L.B., van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 101:(1):1998 Jan 1;273-281
17. Schellekens G.A., Visser H., de Jong B.A., van den Hoogen F.H., Hazes J.M., Breedveld F.C., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43:(1):2000 Jan;155-163
18. Bas S., Perneger T.V., Seitz M., Tiercy J.M., Roux-Lombard P., Guerne P.A. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford). 41:(7):2002 Jul;809-814
19. Tarcsa E., Marekov L.N., Mei G., Melino G., Lee S.C., Steinert P.M. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem. 271:(48):1996 Nov 29;30709-30716
20. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet. 34:(4):2003 Aug;395-402
21. Matsumoto A., Shikata K., Takeuchi F., Kojima N., Mizuochi T. Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J Biochem (Tokyo). 128:(4):2000 Oct;621-628
22. Uesugi M., Yoshida K., Jasin H.E. Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J Immunol. 165:(11):2000 Dec 1;6532-6537
23. Tai A.W., Newkirk M.M. An autoantibody targeting glycated IgG is associated with elevated serum immune complexes in rheumatoid arthritis (RA). Clin Exp Immunol. 120:(1):2000 Apr;188-193
24. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:(11):1987 Nov;1205-1213
25. Menard H.A., Amine E.L.M., Despres N. Rheumatoid arthritis associated sutoimmune systems. J Rheumatol. 25:(5):1998 May;835-837
26. Slack S.L., Mannik M., Dale B.A. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol. 25:(5):1998 May;847-851